Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Report 2026

Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Overview

• Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch market size has reached to $7.04 billion in 2025 • Expected to grow to $13.89 billion in 2030 at a compound annual growth rate (CAGR) of 14.5% • Growth Driver: Rising Prevalence of Diabetes’ Driving The Market Growth Due To Increasing Adoption of Advanced Glucose Monitoring Technologies • Market Trend: Wearable Glucose Sensors Transform Lifestyle And Diabetes Management • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market?

A real-time blood glucose continuous glucose monitoring (CGM) patch is a wearable device that continuously measures glucose levels in the interstitial fluid just beneath the skin. It transmits glucose readings in real time to a connected display or mobile device, allowing for continuous tracking of glucose trends. The patch operates through a small sensor and transmitter that provide frequent data updates without the need for fingerstick measurements. The main product types of real-time blood glucose continuous glucose monitoring (CGM) patch are wearable continuous glucose monitoring (CGM) patch and implantable continuous glucose monitoring (CGM) patch. A wearable continuous glucose monitoring (CGM) patch is a discreet, skin-worn sensor that continuously tracks glucose levels and transmits real-time data to help manage diet, activity, and medication. They are integrated with various technologies, including enzymatic and non-enzymatic, and are distributed through various channels, including online pharmacies, retail pharmacies, hospital pharmacies, and other distribution channels. They are used for various applications, including type 1 diabetes, type 2 diabetes, gestational diabetes, and other applications, and are used by various end-users, including hospitals and clinics, homecare settings, diagnostic centers, and other end-users.

What Is The Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Growth Forecast?

The real-time blood glucose continuous glucose monitoring (cgm) patch market size is expected to see rapid growth in the next few years. It will grow to $13.89 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to integration of real-time data analytics, increasing telehealth adoption, demand for personalized diabetes management, expansion of homecare diagnostics, rising investment in continuous monitoring technologies. Major trends in the forecast period include rising adoption of patch-based glucose monitoring, growing demand for real-time glucose visibility, shift toward non-invasive and minimally invasive monitoring, expansion of home-based diabetes management, increased use of continuous monitoring in early diagnosis.

Global Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Segmentation

1) By Product Type: Wearable Continuous Glucose Monitoring (CGM) Patch, Implantable Continuous Glucose Monitoring (CGM) Patch 2) By Technology: Enzymatic, Non-Enzymatic 3) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels 4) By Application: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Other Applications 5) By End User: Hospitals And Clinics, Homecare Settings, Diagnostic Centers, Other End Users Subsegments: 1) By Wearable Continuous Glucose Monitoring (CGM) Patch: Sensor-Embedded Wearable Continuous Glucose Monitoring (CGM) Patch, Bluetooth-Enabled Wearable Continuous Glucose Monitoring (CGM) Patch, Mobile-Connected Wearable Continuous Glucose Monitoring (CGM) Patch 2) By Implantable Continuous Glucose Monitoring (CGM) Patch: Subcutaneous Implantable Continuous Glucose Monitoring (CGM) Patch, Long-Term Implantable Continuous Glucose Monitoring (CGM) Patch, Miniaturized Implantable Continuous Glucose Monitoring (CGM) Patch

What Is The Driver Of The Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market?

The rising prevalence of diabetes is expected to propel the growth of the real-time blood glucose continuous glucose monitoring (CGM) patch market going forward. Diabetes refers to a chronic metabolic disorder characterized by elevated blood glucose levels due to insufficient insulin production or insulin resistance. The prevalence of diabetes is rising because increasing obesity leads to higher insulin resistance, which disrupts blood sugar regulation and significantly elevates the risk of developing type 2 diabetes. Real-time blood glucose continuous glucose monitoring (CGM) patch enables people with diabetes to continuously track their blood glucose levels in real time, providing timely alerts for hyperglycemia or hypoglycemia, helping them make informed dietary, medication, and lifestyle adjustments, and ultimately improving overall disease management and reducing the risk of complications. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a significant increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore, rising prevalence of diabetes is driving the growth of the real-time blood glucose continuous glucose monitoring (CGM) patch industry.

Key Players In The Global Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market

Major companies operating in the real-time blood glucose continuous glucose monitoring (cgm) patch market are Abbott Laboratories, Dexcom Inc., Medtronic plc, Senseonics Holdings Inc., Medtrum Technologies Inc., Biolinq Inc., MicroTech Medical Inc., Zhejiang POCTech Co. Ltd., SiBio Technology Co. Ltd., Metronom Health Inc., Nemaura Medical Inc., PKvitality SAS, Nutromics Ltd., EOFlow Co. Ltd., i-SENS Inc., Sinocare Inc., Afon Technology Ltd., LifePlus Inc., Ultrahuman Healthcare Pvt. Ltd., Roche Diabetes Care AG, Ascensia Diabetes Care Holdings AG

Global Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Trends and Insights

Major companies operating in the real-time blood glucose continuous glucose monitoring (CGM) patch market are focusing on developing innovative products such as over-the-counter continuous glucose monitoring sensors to expand access and improve user convenience. Over-the-counter continuous glucose monitoring (CGM) sensors are wearable devices that track glucose levels in real time and can be purchased without a prescription, helping users monitor their glucose continuously, understand how lifestyle factors affect their levels, and manage or prevent diabetes more easily. For instance, in September 2024, Dexcom Inc., a US-based diabetes technology company, launched Stelo, its first over-the-counter (OTC) continuous glucose monitoring (CGM) patch in the United States. The small, wearable sensor is applied to the back of the upper arm and provides real-time glucose readings directly to a smartphone app without the need for fingersticks. This is designed for people with Type 2 diabetes not using insulin and those with prediabetes, Stelo delivers personalized insights on how diet, exercise, and sleep affect glucose levels. The device features up to 15-day wear time, waterproofing, spike and pattern detection, and integrates with Dexcom’s proven glucose sensing technology, making continuous glucose monitoring more accessible, convenient, and actionable for a broader population.

What Are Latest Mergers And Acquisitions In The Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market?

In January 2024, Trinity Biotech plc, an Ireland-based diagnostics company, acquired the biosensor and continuous glucose monitoring (CGM) assets of Waveform Technologies, Inc. for $12.5 million in cash and 9 million ADSs. With this acquisition, Trinity Biotech aims to enter the rapidly expanding biosensor and CGM market by leveraging Waveform’s needle-free CGM technology to develop next-generation wearable biosensors that provide actionable health and wellness insights, target additional biomarkers, and enable broader global adoption of affordable diabetes care tools. Waveform Technologies Inc. is a US-based technology company that specializes in providing real-time blood glucose continuous glucose monitoring (CGM) patch technology.

Regional Outlook

North America was the largest region in the real-time blood glucose continuous glucose monitoring (CGM) patch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market?

The real-time blood glucose continuous glucose monitoring (CGM) patch market consists of revenues earned by entities by providing services such as remote patient monitoring and telehealth support, subscription and replacement programs, distribution and logistics management, clinical and diagnostic glucose monitoring services, research and development for sensor innovation, customer training and technical support, and reimbursement or healthcare partnership services. The market value includes the value of related goods sold by the service provider or included within the service offering. The real-time blood glucose continuous glucose monitoring (CGM) patch market also includes sales of microneedles paper-type biodegradable sensor, disposable patch sensor, and adhesive-backed sensor. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.